Colon cancer used to feel like a worry for later-something to think about decades down the road. Not anymore. An estimated ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare ...

Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the American Cancer Society, colorectal cancer is the third-leading cause of ...

New Colon Cancer Screening Guidelines Add Blood And At-Home Tests By Dennis Thompson HealthDay ReporterTHURSDAY, May 28, 2026 (HealthDay News) — Blood tests taken in a doctor’s office now can be used ...

This medical services stock is in a buy zone of a cup base. The firm's losses are dwindling.

When Erica Barnell was an MD/PhD student at Washington University in St. Louis, she met a woman who had stage four colorectal cancer (CRC). The woman was only 52 years old—more than a decade younger ...

Colorectal cancer is now the leading cause of cancer-related death among adults under 50 in the United States, and diagnoses in younger adults continue to increase at an alarming rate. In fact, it has ...

Ontario has lowered the eligibility age for colon cancer screening from 50 to 45, a move that cancer survivor Ashley Wiley ...

As of July 1, Ontarians age 45 and up are eligible to receive the at-home fecal immunochemical screening test — or FIT — that ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...